UK’s Clinical Knowledge Hub • NICE • MHRA • NHS England

Clinical intelligence,
instantly accessible.

Search UK and European guidelines, safety updates, clinical trials, drug mechanisms and CPD resources in one evidence-based platform.

230+ NICE Guidelines
2037+ Clinical Trials
920+ News Articles
Open Education
All Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health Nephrology Haematology
Explore by Specialty All specialties →
Clinical Intelligence
Guidelines
View all guidelines →
NICE Oncology
Ibrutinib with R-CHOP for untreated mantle cell lymphoma when a stem cell transplant is suitable
  • Ibrutinib combined with R-CHOP is recommended for untreated mantle cell lymphoma patients…
  • Ensure patient fitness assessment for stem cell transplant eligibility before initiating ibrutinib…
23 Sep 2026
NICE
Digital technologies to support home monitoring of vision changes for people with advanced dry age-related macular degeneration: early-use assessment
  • Consider recommending digital home monitoring devices (such as Amsler grid apps or…
  • Ensure patients receive adequate training and support in using digital monitoring technology,…
17 Sep 2026
NICE Neurology
Mirdametinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years
  • Mirdametinib is indicated for symptomatic and inoperable plexiform neurofibromas in children aged…
  • Establish baseline assessments including tumour imaging and functional status before starting mirdametinib…
16 Sep 2026
Trial Radar
Clinical Trials
Trial collections View all trials →
PHASE3 Active Not Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 subcutaneous in adult patients with primary immune…
23 Sep 2026
PHASE2, PHASE3 Recruiting
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Neuroblastoma is the most common type of solid cancer found outside the brain in young children. Generally, it affects children…
Oncology
RECRUITING
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants…
Neurology
Drug Science
Molecular Mechanisms
Starter packs Explore mechanisms →
Mechanism Cardiology / Cardiovascular
HMG-CoA Reductase — Statins
• HMG-CoA Reductase — Statins is a clinically relevant Drug Science explainer. • 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase catalyses the rate-limiting step in the mevalonate pathway — the…
Open explainer →
Mechanism Gastroenterology
S1P Receptor Modulation — MS/IBD
• S1P Receptor Modulation — MS/IBD is a clinically relevant Drug Science explainer. • Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite generated by sphingosine kinase-mediated phosphorylation of sphingosine,…
Open explainer →
Mechanism Dermatology
BRAF/MEK Pathway — Melanoma
• BRAF/MEK Pathway — Melanoma is a clinically relevant Drug Science explainer. • The MAPK signalling cascade (RAS-RAF-MEK-ERK) transmits extracellular growth signals from receptor tyrosine kinases to the…
Open explainer →
Latest Updates
Clinical News
View all news →
BBC Health 23 Sep 2026
Barrecore and Boom Cycle owner suddenly shuts studios
Common Bond has emailed customers announcing its locations were closed "until further notice".
Read article →
BBC Health 23 Sep 2026
Why is the price of protein powder rising?
UKHSA 23 Sep 2026
UKHSA expands wastewater surveillance to strengthen ‘early warning system’ for dangerous pathogens
BBC Health 23 Sep 2026
Student almost dies after accidental paracetamol overdose
CPD Accredited
Podcasts & Education
View all podcasts →
Upcoming 0.5 CPD
Drug Interactions: Mechanisms, Red Flags and Practical Management
Dr Anzal Qurbain
Upcoming 0.5 CPD
Polypharmacy and Deprescribing: When Less Is More
Dr Anzal Qurbain
Upcoming 0.5 CPD
Prescribing in Pregnancy: Safe Choices, Teratogens and Risk Communication
Dr Anzal Qurbain
230+Guidelines
2037+Clinical Trials
920+News Articles
15Specialties